幹細胞の世界市場分析:成体幹細胞、hESC、iPS細胞

◆英語タイトル:Stem Cells Market Analysis By Product (Adult Stem Cells, hESC, Induced Pluripotent Stem Cells), By Application (Regenerative Medicine, Drug Discovery), By Technology, By Therapy, And Segment Forecasts, 2014 - 2025
◆商品コード:GVIEW70714031
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2017年6月15日
◆ページ数:150
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥874,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,094,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、幹細胞の世界市場について調査・分析し、幹細胞の世界市場動向、幹細胞の世界市場規模、市場予測、セグメント別幹細胞市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global stem cell market is expected to reach USD 15.63billion by 2025, growing at a CAGR of 9.2%, according to a new report by Grand View Research, Inc. Augmentation in research studies that aim at broadening the utility scope of associated products is anticipated to drive the market growth. These research projects have opened the possibility of implementation of several clinical applications of these cells, thereby impacting disease-modifying treatments.
Scientists are engaged in discovering novel methods to create human stem cells. This is to address the increasing demand for stem cell production for potential investigation in disease management. This factor is certainly expected to accelerate the development of regenerative medicine, thus driving industrial growth.

Moreover, cellular therapies are recognized as the next major advancements in transforming healthcare. Firms are expanding their cellular therapy portfolio, understanding the future potential of this arena in the treatment of Parkinson’s disease, type 1 diabetes, spinal cord injury, Alzheimer’s disease, and others.

In March 2016, Scientists at Michigan State University unveiled new kind of cells “induced XEN cells” from a cellular trash pile. This discovery is expected to drive advancements in regenerative medicine. Such discoveries are anticipated to bolster research and sales in this market over the forecast period.

Further key findings from the report suggest:

• Adult stem cells dominated the market and is expected to maintain its dominance. This can be attributed to the several factors such as lower rejection rates, long term renewal property, and no ethical concerns associated with their usage

• Application wise regenerative medicine is estimated to hold the substantial share of the revenue

• Presence of significant number pipeline projects for regenerative medicine is expected to fuel growth in the market

• In addition, exploding research projects have driven the need of harvesting techniques, thereby propelling progress of acquisition technology

• Increased R&D activities and huge funds granted by funding bodies to advance cellular research in the U.S. have resulted into the large share of North America

• Extensive research carried out in Singapore and Japan is anticipated to drive progress with lucrative avenues

• Advanced Cell Technology Inc, Osiris Therapeutics Inc, Celgene Corporation, BIOTIME, INC., Cynata, and STEMCELL Technologies Inc., are some of the major companies operating in this market

• A number of companies are engaged in seeking investment from overseas organizations and also developing partnerships with the pharmaceutical organizations

【レポートの目次】

Table of content

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Stem Cell Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Ongoing developments in regenerative medicine
3.1.1.2 Rising funds for accelerating stem cell research
3.1.1.3 Growing demand for stem cell banking
3.1.1.4 Increasing prevalence of genetic disorders
3.1.2 Market Restraint Analysis
3.1.2.1 Ethical concern related to stem cell research
3.1.2.2 Lack of well-defined regulatory framework in certain applications of stem cell
3.2 Penetration & Growth Prospect Mapping for Application, 2016
3.3 Pipleline Analysis
3.4 Stem Cells -SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Industry Analysis – Porter’s
Chapter 4 Stem Cell Market: Product Estimates & Trend Analysis
4.1 Global Stem Cells Market: Product Movement Analysis
4.2 Adult Stem Cells
4.2.1 Global adult stem cells market, 2014 – 2025 (USD Billion)
4.2.2 Neuronal stem cells
4.2.2.1 Global neuronal stem cells market, 2014 – 2025 (USD Billion)
4.2.3 Hematopoietic stem cells
4.2.3.1 Global hematopoietic stem cells market, 2014 – 2025 (USD Billion)
4.2.4 Mesenchymal stem cells
4.2.4.1 Global mesenchymal stem cells market, 2014 – 2025 (USD Billion)
4.2.5 Umbilical cord stem cells
4.2.5.1 Global umbilical cord stem cells market, 2014 – 2025 (USD Billion)
4.2.6 Others
4.2.6.1 Global other stem cells market, 2014 – 2025 (USD Billion)
4.3 Human Embryonic Stem Cells
4.3.1 Global human embryonic stem cells market, 2014 – 2025 (USD Billion)
4.4 Induced Pluripotent Stem Cells
4.4.1 Global induced pluripotent stem cells market, 2014 – 2025 (USD Billion)
4.5 Very Small Embryonic Like Stem Cells
4.5.1 Global very small embryonic like stem cells market, 2014 – 2025 (USD Billion)
Chapter 5 Stem Cell Market: Application Estimates & Trend Analysis
5.1 Global Stem Cells Market: Applications Movement Analysis
5.2 Regenerative Medicine
5.2.1 Global regenerative medicine market, 2014 – 2025 (USD Billion)
5.2.2 Neurology
5.2.2.1 Global neurology market, 2014 – 2025 (USD Billion)
5.2.3 Orthopedics
5.2.3.1 Global orthopedics market, 2014 – 2025 (USD Billion)
5.2.4 Oncology
5.2.4.1 Global oncology market, 2014 – 2025 (USD Billion)
5.2.5 Hematology
5.2.5.1 Global hematology market, 2014 – 2025 (USD Billion)
5.2.6 Cardiovascular and myocardial infraction
5.2.6.1 Global cardiovascular and myocardial infraction market, 2014 – 2025 (USD Billion)
5.2.7 Injuries
5.2.7.1 Global injuries market, 2014 – 2025 (USD Billion)
5.2.8 Diabetes
5.2.8.1 Global diabetes market, 2014 – 2025 (USD Billion)
5.2.9 Liver disorder
5.2.9.1 Global liver disorder market, 2014 – 2025 (USD Billion)
5.2.10 Incontinence
5.2.10.1 Global incontinence market, 2014 – 2025 (USD Billion)
5.2.11 Others
5.2.11.1 Global others market, 2014 – 2025 (USD Billion)
5.3 Drug Discovery and Development
5.3.1 Global drug discovery and development market, 2014 – 2025 (USD Billion)
Chapter 6 Stem Cell Market: Technology Estimates & Trend Analysis
6.1 Global Stem cells Market: Technology Movement Analysis
6.2 Cell Acquisition
6.2.1 Global cell acquisition market, 2014 – 2025 (USD Billion)
6.2.2 Bone marrow harvest
6.2.2.1 Global bone marrow harvest market, 2014 – 2025 (USD Billion)
6.2.3 Umbilical blood cord
6.2.3.1 Global umbilical blood cord market, 2014 – 2025 (USD Billion)
6.2.4 Apheresis
6.2.4.1 Global apheresis market, 2014 – 2025 (USD Billion)
6.3 Cell Production
6.3.1 Global cell production market, 2014 – 2025 (USD Billion)
6.3.2 Therapeutic cloning
6.3.2.1 Global therapeutic cloning market, 2014 – 2025 (USD Billion)
6.3.3 In-vitro fertilization
6.3.3.1 Global in vitro fertilization market, 2014 – 2025 (USD Billion)
6.3.4 Cell culture
6.3.4.1 Global cell culture market, 2014 – 2025 (USD Billion)
6.3.5 Isolation
6.3.5.1 Global isolation market, 2014 – 2025 (USD Billion)
6.4 Cryopreservation
6.4.1 Global cryopreservation market, 2014 – 2025 (USD Billion)
6.5 Expansion and Sub-Culture
6.5.1 Global expansion and sub-culture market, 2014 – 2025 (USD Billion)
Chapter 7 Stem Cell: Therapy Estimates & Trend Analysis
7.1 Global Stem Cells Market: Therapy Movement Analysis
7.2 Autologous
7.2.1 Global autologous market, 2014 – 2025 (USD Billion)
7.3 Allogenic
7.3.1 Global allogenic market, 2014 – 2025 (USD Billion)
Chapter 8 Stem Cell Market: Regional Estimates & Trend Analysis, by Product, Application, Technology, And Therapy
8.1 Stem Cells Market Share by Region, 2016 & 2025
8.2 North America
8.2.1 North America stem cells market, by product 2014 – 2025 (USD Billion)
8.2.1.1 North America adult stem cells market, by product 2014 – 2025 (USD Billion)
8.2.2 North America stem cells market, by application 2014 – 2025 (USD Billion)
8.2.2.1 North America regenerative medicine market, by application 2014 – 2025 (USD Billion)
8.2.3 North America stem cells market, by technology 2014 – 2025 (USD Billion)
8.2.3.1 North America cell acquisition market, technology 2014 – 2025 (USD Billion)
8.2.3.2 North America cell production market, by technology 2014 – 2025 (USD Billion)
8.2.4 North America stem cells market, by therapy 2014 – 2025 (USD Billion)
8.2.5 U.S.
8.2.5.1 U.S. stem cells market, by product 2014 – 2025 (USD Billion)
8.2.5.1.1 U.S. adult stem cells market, by product 2014 – 2025 (USD Billion)
8.2.5.2 U.S. stem cells market, by application 2014 – 2025 (USD Billion)
8.2.5.2.1 U.S. regenerative medicine market, by application 2014 – 2025 (USD Billion)
8.2.5.3 U.S. stem cells market, by technology 2014 – 2025 (USD Billion)
8.2.5.3.1 U.S. cell acquisition market, technology 2014 – 2025 (USD Billion)
8.2.5.3.2 U.S. cell production market, by technology 2014 – 2025 (USD Billion)
8.2.5.4 U.S. stem cells market, by therapy 2014 – 2025 (USD Billion)
8.3 Europe
8.3.1 Europe stem cells market, by product 2014 – 2025 (USD Billion)
8.3.1.1 Europe adult stem cells market, by product 2014 – 2025 (USD Billion)
8.3.2 Europe stem cells market, by application 2014 – 2025 (USD Billion)
8.3.2.1 Europe regenerative medicine market, by application 2014 – 2025 (USD Billion)
8.3.3 Europe stem cells market, by technology 2014 – 2025 (USD Billion)
8.3.3.1 Europe cell acquisition market, technology 2014 – 2025 (USD Billion)
8.3.3.2 Europe cell production market, by technology 2014 – 2025 (USD Billion)
8.3.4 Europe stem cells market, by therapy 2014 – 2025 (USD Billion)
8.3.5 Germany
8.3.5.1 Germany stem cells market, by product 2014 – 2025 (USD Billion)
8.3.5.1.1 Germany adult stem cells market, by product 2014 – 2025 (USD Billion)
8.3.5.2 Germany stem cells market, by application 2014 – 2025 (USD Billion)
8.3.5.3 Germany regenerative medicine market, by application 2014 – 2025 (USD Billion)
8.3.5.4 Germany stem cells market, by technology 2014 – 2025 (USD Billion)
8.3.5.3.1 Germany cell acquisition market, technology 2014 – 2025 (USD Billion)
8.3.5.3.2 Germany cell production market, by technology 2014 – 2025 (USD Billion)
8.3.5.5 Germany stem cells market, by therapy 2014 – 2025 (USD Billion)
8.3.6 UK
8.3.6.1 UK stem cells market, by product 2014 – 2025 (USD Billion)
8.3.6.1.1 UK adult stem cells market, by product 2014 – 2025 (USD Billion)
8.3.6.2 UK stem cells market, by application 2014 – 2025 (USD Billion)
8.3.6.2.1 UK regenerative medicine market, by application 2014 – 2025 (USD Billion)
8.3.6.3 UK stem cells market, by technology 2014 – 2025 (USD Billion)
8.3.6.3.1 UK cell acquisition market, technology 2014 – 2025 (USD Billion)
8.3.6.3.2 UK cell production market, by technology 2014 – 2025 (USD Billion)
8.3.6.4 UK stem cells market, by therapy 2014 – 2025 (USD Billion)
8.4 Asia Pacific
8.4.1 Asia Pacific stem cells market, by product 2014 – 2025 (USD Billion)
8.4.1.1 Asia Pacific adult stem cells market, by product 2014 – 2025 (USD Billion)
8.4.2 Asia Pacific stem cells market, by application 2014 – 2025 (USD Billion)
8.4.2.1 Asia Pacific regenerative medicine market, by application 2014 – 2025 (USD Billion)
8.4.3 Asia Pacific stem cells market, by technology 2014 – 2025 (USD Billion)
8.4.3.1 Asia Pacific cell acquisition market, technology 2014 – 2025 (USD Billion)
8.4.3.2 Asia Pacific cell production market, by technology 2014 – 2025 (USD Billion)
8.4.4 Asia Pacific stem cells market, by therapy 2014 – 2025 (USD Billion)
8.4.5 Japan
8.4.5.1 Japan stem cells market, by product 2014 – 2025 (USD Billion)
8.4.5.1.1 Japan adult stem cells market, by product 2014 – 2025 (USD Billion)
8.4.5.2 Japan stem cells market, by application 2014 – 2025 (USD Billion)
8.4.5.2.1 Japan regenerative medicine market, by application 2014 – 2025 (USD Billion)
8.4.5.3 Japan stem cells market, by technology 2014 – 2025 (USD Billion)
8.4.5.3.1 Japan cell acquisition market, technology 2014 – 2025 (USD Billion)
8.4.5.3.2 Japan cell production market, by technology 2014 – 2025 (USD Billion)
8.4.5.4 Japan stem cells market, by therapy 2014 – 2025 (USD Billion)
8.4.6 China
8.4.6.1 China stem cells market, by product 2014 – 2025 (USD Billion)
8.4.6.1.1 China adult stem cells market, by product 2014 – 2025 (USD Billion)
8.4.6.2 China stem cells market, by application 2014 – 2025 (USD Billion)
8.4.6.2.1 China regenerative medicine market, by application 2014 – 2025 (USD Billion)
8.4.6.3 China stem cells market, by technology 2014 – 2025 (USD Billion)
8.4.6.3.1 China cell acquisition market, technology 2014 – 2025 (USD Billion)
8.4.6.3.2 China cell production market, by technology 2014 – 2025 (USD Billion)
8.4.6.4 China stem cells market, by therapy 2014 – 2025 (USD Billion)
8.5 Latin America
8.5.1 Latin America stem cells market, by product 2014 – 2025 (USD Billion)
8.5.1.1 Latin America adult stem cells market, by product 2014 – 2025 (USD Billion)
8.5.2 Latin America stem cells market, by application 2014 – 2025 (USD Billion)
8.5.2.1 Latin America regenerative medicine market, by application 2014 – 2025 (USD Billion)
8.5.3 Latin America stem cells market, by technology 2014 – 2025 (USD Billion)
8.5.3.1 Latin America cell acquisition market, technology 2014 – 2025 (USD Billion)
8.5.3.2 Latin America cell production market, by technology 2014 – 2025 (USD Billion)
8.5.4 Latin America stem cells market, by therapy 2014 – 2025 (USD Billion)
8.5.5 Brazil
8.5.5.1 Brazil stem cells market, by product 2014 – 2025 (USD Billion)
8.5.5.1.1 Brazil adult stem cells market, by product 2014 – 2025 (USD Billion)
8.5.5.2 Brazil stem cells market, by application 2014 – 2025 (USD Billion)
8.5.5.2.1 Brazil regenerative medicine market, by application 2014 – 2025 (USD Billion)
8.5.5.3 Brazil stem cells market, by technology 2014 – 2025 (USD Billion)
8.5.5.3.1 Brazil cell acquisition market, technology 2014 – 2025 (USD Billion)
8.5.5.3.2 Brazil cell production market, by technology 2014 – 2025 (USD Billion)
8.5.5.4 Brazil stem cells market, by therapy 2014 – 2025 (USD Billion)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa (MEA) stem cells market, by product 2014 – 2025 (USD Billion)
8.6.1.1 Middle East & Africa (MEA) adult stem cells market, by product 2014 – 2025 (USD Billion)
8.6.2 Middle East & Africa (MEA) stem cells market, by application 2014 – 2025 (USD Billion)
8.6.2.1 Middle East & Africa (MEA) regenerative medicine market, by application 2014 – 2025 (USD Billion)
8.6.3 Middle East & Africa (MEA) stem cells market, by technology 2014 – 2025 (USD Billion)
8.6.3.1 Middle East & Africa (MEA) cell acquisition market, technology 2014 – 2025 (USD Billion)
8.6.3.2 Middle East & Africa (MEA) cell production market, by technology 2014 – 2025 (USD Billion)
8.6.4 Middle East & Africa (MEA) stem cells market, by therapy 2014 – 2025 (USD Billion)
8.6.5 South Africa
8.6.5.1 South Africa stem cells market, by product 2014 – 2025 (USD Billion)
8.6.5.1.1 South Africa adult stem cells market, by product 2014 – 2025 (USD Billion)
8.6.5.2 South Africa stem cells market, by application 2014 – 2025 (USD Billion)
8.6.5.2.1 South Africa regenerative medicine market, by application 2014 – 2025 (USD Billion)
8.6.5.3 South Africa stem cells market, by technology 2014 – 2025 (USD Billion)
8.6.5.3.1 South Africa cell acquisition market, technology 2014 – 2025 (USD Billion)
8.6.5.3.2 South Africa cell production market, by technology 2014 – 2025 (USD Billion)
8.6.5.4 South Africa stem cells market, by therapy 2014 – 2025 (USD Billion)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Advanced Cell Technology Inc.
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Product benchmarking
9.3.1.4 Strategic initiatives
9.3.2 STEMCELL Technologies Inc.
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 BIOTIME, INC.
9.3.3.1 Company overview
9.3.3.2 Cell Cure Neurosciences LTD.
9.3.3.3 ESI BIO
9.3.3.4 Financial performance
9.3.3.5 Product benchmarking
9.3.3.6 Strategic initiatives
9.3.4 Cellular Engineering Technologies Inc.
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 CellGenix GmbH
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 PromoCell GmbH
9.3.6.1 Company overview
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Lonza
9.3.7.1 Company overview
9.3.7.2 Financial performance
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Kite Pharma
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Cellartis AB
9.3.9.1 Company overview
9.3.9.2 Financial performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Angel Biotechnology
9.3.10.1 Company overview
9.3.10.2 Financial performance
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.3.11 BrainStorm Cell Therapeutics
9.3.11.1 Company overview
9.3.11.2 Financial performance
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives
9.3.12 Celgene Corporation
9.3.12.1 Company overview
9.3.12.2 Financial performance
9.3.12.3 Product benchmarking
9.3.12.4 Strategic initiatives
9.3.13 Osiris Therapeutics
9.3.13.1 Company overview
9.3.13.2 Financial performance
9.3.13.3 Product benchmarking
9.3.13.4 Strategic initiatives
9.3.14 Genea BioCells
9.3.14.1 Company overview
9.3.14.2 Financial performance
9.3.14.3 Product benchmarking
9.3.14.4 Strategic initiatives
9.3.15 Bioheart Inc.
9.3.15.1 Company overview
9.3.15.2 Financial performance
9.3.15.3 Product benchmarking
9.3.15.4 Strategic initiatives
9.3.16 Waisman Biomanufacturing
9.3.16.1 Company overview
9.3.16.2 Financial performance
9.3.16.3 Product benchmarking
9.3.16.4 Strategic initiatives
9.3.17 TiGenix
9.3.17.1 Company overview
9.3.17.2 Financial performance
9.3.17.3 Product benchmarking
9.3.17.4 Strategic initiatives
9.3.18 Caladrius
9.3.18.1 Company overview
9.3.18.2 Financial performance
9.3.18.3 Product benchmarking
9.3.18.4 Strategic initiatives
9.3.19 Gamida Cell.
9.3.19.1 Company overview
9.3.19.2 Financial performance
9.3.19.3 Product benchmarking
9.3.19.4 Strategic initiatives
9.3.20 Pluristem
9.3.20.1 Company overview
9.3.20.2 Financial performance
9.3.20.3 Product benchmarking
9.3.20.4 Strategic initiatives
9.3.21 TiGenix
9.3.21.1 Company overview
9.3.21.2 Financial performance
9.3.21.3 Product benchmarking
9.3.21.4 Strategic initiatives

List of Tables

TABLE 1 North America stem cells market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 2 North America adult stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 3 North America stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 4 North America regenerative medicine market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 5 North America stem cells market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 6 North America cell acquisition technology market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 7 North America cell production market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 8 North America stem cell market estimates & forecasts, by therapy, 2014 - 2025 (USD Billion)
TABLE 9 U.S. stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 10 U.S. adult stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 11 U.S. stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 12 U.S. regenerative medicine market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 13 U.S. stem cells market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 14 U.S. cell acquisition technology market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 15 U.S. cell production market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 16 U.S. stem cell market estimates& forecasts, by therapy, 2014 - 2025 (USD Billion)
TABLE 17 Canada stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 18 Canada adult stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 19 Canada stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 20 Canada regenerative medicine market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 21 Canada stem cells market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 22 Canada cell acquisition technology market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 23 Canada cell production market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 24 Canada stem cell market estimates& forecasts, by therapy, 2014 - 2025 (USD Billion)
TABLE 25 Europe stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 26 Europe adult stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 27 Europe stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 28 Europe regenerative medicine market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 29 Europe stem cells market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 30 Europe cell acquisition technology market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 31 Europe cell production market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 32 Europe stem cell market estimates& forecasts, by therapy, 2014 - 2025 (USD Billion)
TABLE 33 Germany stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 34 Germany adult stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 35 Germany stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 36 Germany regenerative medicine market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 37 Germany stem cells market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 38 Germany cell acquisition technology market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 39 Germany cell production market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 40 Germany stem cell market estimates& forecasts, by therapy, 2014 - 2025 (USD Billion)
TABLE 41 UK stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 42 UK adult stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 43 UK stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 44 UK regenerative medicine market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 45 UK stem cells market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 46 UK cell acquisition technology market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 47 UK cell production market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 48 UK stem cell market estimates& forecasts, by therapy, 2014 - 2025 (USD Billion)
TABLE 49 Asia Pacific stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 50 Asia Pacific adult stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 51 Asia Pacific stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 52 Asia Pacific regenerative medicine market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 53 Asia Pacific stem cells market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 54 Asia Pacific cell acquisition technology market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 55 Asia Pacific cell production market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 56 Asia Pacific stem cell market estimates& forecasts, by therapy, 2014 - 2025 (USD Billion)
TABLE 57 Japan stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 58 Japan adult stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 59 Japan stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 60 Japan regenerative medicine market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 61 Japan stem cells market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 62 Japan cell acquisition technology market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 63 Japan cell production market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 64 Japan stem cell market estimates& forecasts, by therapy, 2014 - 2025 (USD Billion)
TABLE 65 China stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 66 China adult stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 67 China stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 68 China regenerative medicine market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 69 China stem cells market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 70 China cell acquisition technology market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 71 China cell production market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 72 China stem cell market estimates& forecasts, by therapy, 2014 - 2025 (USD Billion)
TABLE 73 Latin America stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 74 Latin America adult stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 75 Latin America stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 76 Latin America regenerative medicine market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 77 Latin America stem cells market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 78 Latin America cell acquisition technology market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 79 Latin America cell production market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 80 Latin America stem cell market estimates& forecasts, by therapy, 2014 - 2025 (USD Billion)
TABLE 81 Brazil stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 82 Brazil adult stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 83 Brazil stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 84 Brazil regenerative medicine market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 85 Brazil stem cells market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 86 Brazil cell acquisition technology market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 87 Brazil cell production market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 88 Brazil stem cell market estimates& forecasts, by therapy, 2014 - 2025 (USD Billion)
TABLE 89 Middle East & Africa stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 90 Middle East & Africa adult stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 91 Middle East & Africa stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 92 Middle East & Africa regenerative medicine market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 93 Middle East & Africa stem cells market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 94 Middle East & Africa cell acquisition technology market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 95 Middle East & Africa cell production market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 96 Middle East & Africa stem cell market estimates& forecasts, by therapy, 2014 - 2025 (USD Billion)
TABLE 97 South Africa stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 98 South Africa adult stem cells market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 99 South Africa stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 100 South Africa regenerative medicine market estimates& forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 101 South Africa stem cells market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 102 South Africa cell acquisition technology market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 103 South Africa cell production market estimates& forecasts, by technology, 2014 - 2025 (USD Billion)
TABLE 104 South Africa stem cell market estimates& forecasts, by therapy, 2014 - 2025 (USD Billion)

List of Figures

FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping for Application, 2016
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Global stem cells market: Product outlook key takeaways
FIG. 16 Global stem cells market: Product movement analysis
FIG. 17 Global adult stem cells market, 2014 - 2025 (USD Million)
FIG. 18 Global neuronal stem cells market, 2014 - 2025 (USD Million)
FIG. 19 Global hematopoietic stem cells market, 2014 - 2025 (USD Million)
FIG. 20 Global mesenchymal stem cells market, 2014 - 2025 (USD Million)
FIG. 21 Global umbilical cord stem cells market, 2014 - 2025 (USD Million)
FIG. 22 Global others market, 2014 - 2025 (USD Million)
FIG. 23 Global human embryonic stem cells market, 2014 - 2025 (USD Million)
FIG. 24 Global induced pluripotent stem cells market, 2014 - 2025 (USD Million)
FIG. 25 Global very small embryonic like stem cells market, 2014 - 2025 (USD Million)
FIG. 26 Global stem cells market: Application outlook key takeaways
FIG. 27 Global stem cells market: Application movement analysis
FIG. 28 Global regenerative medicine market, 2014 - 2025 (USD Million)
FIG. 29 Global neurology market, 2014 - 2025 (USD Million)
FIG. 30 Global orthopedics market, 2014 - 2025 (USD Million)
FIG. 31 Global oncology market, 2014 - 2025 (USD Million)
FIG. 32 Global hematology market, 2014 - 2025 (USD Million)
FIG. 33 Global cardiovascular and myocardial infraction market, 2014 - 2025 (USD Million)
FIG. 34 Global injuries market, 2014 - 2025 (USD Million)
FIG. 35 Global diabetes market, 2014 - 2025 (USD Million)
FIG. 36 Global liver disorder market, 2014 - 2025 (USD Million)
FIG. 37 Global incontinence market, 2014 - 2025 (USD Million)
FIG. 38 Global drug discovery and development market, 2014 - 2025 (USD Million)
FIG. 39 Global Stem cells market: Technology outlook key takeaways
FIG. 40 Global Stem cells market: Technology movement analysis
FIG. 41 Global cell acquisition market, 2014 - 2025 (USD Million)
FIG. 42 Global bone marrow harvest market, 2014 - 2025 (USD Million)
FIG. 43 Global umbilical blood cord market, 2014 - 2025 (USD Million)
FIG. 44 Global apheresis market, 2014 - 2025 (USD Million)
FIG. 45 Global cell production market, 2014 - 2025 (USD Million)
FIG. 46 Global therapeutic cloning market, 2014 - 2025 (USD Million)
FIG. 47 Global in vitro fertilization market, 2014 - 2025 (USD Million)
FIG. 48 Global cell culture market, 2014 - 2025 (USD Million)
FIG. 49 Global isolation market, 2014 - 2025 (USD Million)
FIG. 50 Global cryopreservation market, 2014 - 2025 (USD Million)
FIG. 51 Global expansion and sub-culture market, 2014 - 2025 (USD Million)
FIG. 52 Global Stem cells market: Type outlook key takeaways
FIG. 53 Global Stem cells market: Type movement analysis
FIG. 54 Global autologous market, 2014 - 2025 (USD Million)
FIG. 55 Global allogenic market, 2014 - 2025 (USD Million)
FIG. 56 Regional market place: Key takeaway
FIG. 57 Stem cells regional outlook, 2016 & 2025
FIG. 58 North America stem cells market, 2014 - 2025 (USD Million)
FIG. 59 U.S stem cells market, 2014 - 2025 (USD Million)
FIG. 60 Canada stem cells market, 2014 - 2025 (USD Million)
FIG. 61 Europe stem cells market, 2014 - 2025 (USD Million)
FIG. 62 Germany stem cells market, 2014 - 2025 (USD Million)
FIG. 63 UK stem cells market, 2014 - 2025 (USD Million)
FIG. 64 Asia Pacific stem cells market, 2014 - 2025 (USD Million)
FIG. 65 Japan stem cells market, 2014 - 2025 (USD Million)
FIG. 66 China stem cells market, 2014 - 2025 (USD Million)
FIG. 67 Latin America stem cells market, 2014 - 2025 (USD Million)
FIG. 68 Brazil stem cells market, 2014 - 2025 (USD Million)
FIG. 69 Middle East & Africa stem cells market, 2014 - 2025 (USD Million)
FIG. 70 South Africa stem cells market, 2014 - 2025 (USD Million)
FIG. 71 Strategy framework
FIG. 72 Participant categorization

【レポートのキーワード】

幹細胞、成体幹細胞、hESC、iPS細胞、再生医療、創薬

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 幹細胞の世界市場分析:成体幹細胞、hESC、iPS細胞(Stem Cells Market Analysis By Product (Adult Stem Cells, hESC, Induced Pluripotent Stem Cells), By Application (Regenerative Medicine, Drug Discovery), By Technology, By Therapy, And Segment Forecasts, 2014 - 2025)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆